🎁 Black Friday: up to 50% off of annual plans
GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,670.00
-215.00 (-7.45%)
Sep 6, 2026, 3:08 AM KST

GeneOne Life Science Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-52,875-51,851-48,537-77,768-38,150-15,888
Depreciation & Amortization
17,04118,19617,96112,7765,4244,650
Loss (Gain) From Sale of Assets
-4.55-43.83-2.82-3.4-1.31106.64
Asset Writedown & Restructuring Costs
---32,309--
Loss (Gain) From Sale of Investments
4,060-4.25---
Provision & Write-off of Bad Debts
167.771572.7-845.521,293111.17
Other Operating Activities
16,69511,0108,4423,1713,579-2,084
Change in Accounts Receivable
2,0165,069407.864,835-2,84868.06
Change in Inventory
3,8112,005-2,096-207.63-4,256-2,415
Change in Accounts Payable
5,9993,45610,2403,801-10,00310,610
Change in Income Taxes
-18.34-----97.74
Change in Other Net Operating Assets
-6,507-4,416-1,987188.3320,850-194.83
Operating Cash Flow
-9,737-16,541-16,058-21,744-24,113-4,849
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,243-23.82-3,298-5,601-45,306-82,442
Sale of Property, Plant & Equipment
1,18348.182.1215.7-29.13
Sale (Purchase) of Intangibles
-9.88-35.25-69.14-51.59-101.81-75.24
Investment in Securities
258.5-698470.7931,52953,000-57,000
Other Investing Activities
11043446-0-151.33-5,961
Investing Cash Flow
-196.5-769.89-2,84525,8928,055-146,398

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-30,8731,3523,792701.151,054
Long-Term Debt Issued
-6,2469,2246,27111,469-
Total Debt Issued
17,04037,11910,57610,06312,1711,054
Short-Term Debt Repaid
--16,879-506.85-2,100--150.86
Long-Term Debt Repaid
--3,836-2,700-18,712-5,537-1,639
Total Debt Repaid
-15,820-20,715-3,207-20,812-5,537-1,790
Net Debt Issued (Repaid)
1,22016,4047,369-10,7496,633-735.35
Issuance of Common Stock
8,0691,0003,5902,470382.44112,609
Other Financing Activities
8046.91-0-5.64-2.97-849.86
Financing Cash Flow
9,36917,45110,959-8,2857,013111,023

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.84-1.1813.81-13.29-3.42101.37
Miscellaneous Cash Flow Adjustments
-0-00-00
Net Cash Flow
-569.98138.54-7,931-4,150-9,049-40,122

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-10,980-16,565-19,356-27,345-69,419-87,291
Free Cash Flow Growth
------
Free Cash Flow Margin
-121.05%-71.88%-54.19%-68.02%-142.49%-225.56%
Free Cash Flow Per Share
-607.17-1004.30-1217.99-1758.52-4479.48-5878.87
Levered Free Cash Flow
8,5763,4872,211-22,581-73,691-103,116
Unlevered Free Cash Flow
11,7956,7003,558-21,843-69,123-100,332

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-54.2674.6682.1558.5-
Cash Income Tax Paid
--103.42-236.05104.9326.55189.71
Change in Working Capital
5,1785,9916,0718,6173,7438,255